117 related articles for article (PubMed ID: 27463859)
1. Experimental Active-Site Mapping by Fragments: Hot Spots Remote from the Catalytic Center of Endothiapepsin.
Radeva N; Krimmer SG; Stieler M; Fu K; Wang X; Ehrmann FR; Metz A; Huschmann FU; Weiss MS; Mueller U; Schiebel J; Heine A; Klebe G
J Med Chem; 2016 Aug; 59(16):7561-75. PubMed ID: 27463859
[TBL] [Abstract][Full Text] [Related]
2. Structure-Based Optimization of Inhibitors of the Aspartic Protease Endothiapepsin.
Hartman AM; Mondal M; Radeva N; Klebe G; Hirsch AK
Int J Mol Sci; 2015 Aug; 16(8):19184-94. PubMed ID: 26287174
[TBL] [Abstract][Full Text] [Related]
3. Tracing binding modes in hit-to-lead optimization: chameleon-like poses of aspartic protease inhibitors.
Kuhnert M; Köster H; Bartholomäus R; Park AY; Shahim A; Heine A; Steuber H; Klebe G; Diederich WE
Angew Chem Int Ed Engl; 2015 Feb; 54(9):2849-53. PubMed ID: 25630461
[TBL] [Abstract][Full Text] [Related]
4. Fragment Linking and Optimization of Inhibitors of the Aspartic Protease Endothiapepsin: Fragment-Based Drug Design Facilitated by Dynamic Combinatorial Chemistry.
Mondal M; Radeva N; Fanlo-Virgós H; Otto S; Klebe G; Hirsch AK
Angew Chem Int Ed Engl; 2016 Aug; 55(32):9422-6. PubMed ID: 27400756
[TBL] [Abstract][Full Text] [Related]
5. The structure of endothiapepsin complexed with a Phe-Tyr reduced-bond inhibitor at 1.35 Å resolution.
Guo J; Cooper JB; Wood SP
Acta Crystallogr F Struct Biol Commun; 2014 Jan; 70(Pt 1):30-3. PubMed ID: 24419612
[TBL] [Abstract][Full Text] [Related]
6. Active Site Mapping of an Aspartic Protease by Multiple Fragment Crystal Structures: Versatile Warheads To Address a Catalytic Dyad.
Radeva N; Schiebel J; Wang X; Krimmer SG; Fu K; Stieler M; Ehrmann FR; Metz A; Rickmeyer T; Betz M; Winquist J; Park AY; Huschmann FU; Weiss MS; Mueller U; Heine A; Klebe G
J Med Chem; 2016 Nov; 59(21):9743-9759. PubMed ID: 27726357
[TBL] [Abstract][Full Text] [Related]
7. Experimental and computational active site mapping as a starting point to fragment-based lead discovery.
Behnen J; Köster H; Neudert G; Craan T; Heine A; Klebe G
ChemMedChem; 2012 Feb; 7(2):248-61. PubMed ID: 22213702
[TBL] [Abstract][Full Text] [Related]
8. A small nonrule of 3 compatible fragment library provides high hit rate of endothiapepsin crystal structures with various fragment chemotypes.
Köster H; Craan T; Brass S; Herhaus C; Zentgraf M; Neumann L; Heine A; Klebe G
J Med Chem; 2011 Nov; 54(22):7784-96. PubMed ID: 21972967
[TBL] [Abstract][Full Text] [Related]
9. Alzheimer's disease: identification and development of β-secretase (BACE-1) binding fragments and inhibitors by dynamic ligation screening (DLS).
Fernández-Bachiller MI; Horatscheck A; Lisurek M; Rademann J
ChemMedChem; 2013 Jul; 8(7):1041-56. PubMed ID: 23757181
[TBL] [Abstract][Full Text] [Related]
10. Application of fragment screening by X-ray crystallography to the discovery of aminopyridines as inhibitors of beta-secretase.
Congreve M; Aharony D; Albert J; Callaghan O; Campbell J; Carr RA; Chessari G; Cowan S; Edwards PD; Frederickson M; McMenamin R; Murray CW; Patel S; Wallis N
J Med Chem; 2007 Mar; 50(6):1124-32. PubMed ID: 17315857
[TBL] [Abstract][Full Text] [Related]
11. Design and Synthesis of Bioisosteres of Acylhydrazones as Stable Inhibitors of the Aspartic Protease Endothiapepsin.
Jumde VR; Mondal M; Gierse RM; Unver MY; Magari F; van Lier RCW; Heine A; Klebe G; Hirsch AKH
ChemMedChem; 2018 Nov; 13(21):2266-2270. PubMed ID: 30178575
[TBL] [Abstract][Full Text] [Related]
12. X-ray analyses of aspartic proteinases. III Three-dimensional structure of endothiapepsin complexed with a transition-state isostere inhibitor of renin at 1.6 A resolution.
Veerapandian B; Cooper JB; Sali A; Blundell TL
J Mol Biol; 1990 Dec; 216(4):1017-29. PubMed ID: 2266553
[TBL] [Abstract][Full Text] [Related]
13. Fragment-based discovery of BACE1 inhibitors using functional assays.
Godemann R; Madden J; Krämer J; Smith M; Fritz U; Hesterkamp T; Barker J; Höppner S; Hallett D; Cesura A; Ebneth A; Kemp J
Biochemistry; 2009 Nov; 48(45):10743-51. PubMed ID: 19799414
[TBL] [Abstract][Full Text] [Related]
14. Thermodynamic mapping of the inhibitor site of the aspartic protease endothiapepsin.
Gómez J; Freire E
J Mol Biol; 1995 Sep; 252(3):337-50. PubMed ID: 7563055
[TBL] [Abstract][Full Text] [Related]
15. One Question, Multiple Answers: Biochemical and Biophysical Screening Methods Retrieve Deviating Fragment Hit Lists.
Schiebel J; Radeva N; Köster H; Metz A; Krotzky T; Kuhnert M; Diederich WE; Heine A; Neumann L; Atmanene C; Roecklin D; Vivat-Hannah V; Renaud JP; Meinecke R; Schlinck N; Sitte A; Popp F; Zeeb M; Klebe G
ChemMedChem; 2015 Sep; 10(9):1511-21. PubMed ID: 26259992
[TBL] [Abstract][Full Text] [Related]
16. Binding of phosphinate and phosphonate inhibitors to aspartic proteases: a first-principles study.
Vidossich P; Carloni P
J Phys Chem B; 2006 Jan; 110(3):1437-42. PubMed ID: 16471695
[TBL] [Abstract][Full Text] [Related]
17. Study on the active mechanism of β-secretase inhibitors by molecular simulations.
Tian YL; Lv M; Li JJ; Xu T; Zhai HL; Zhang XY
Eur J Pharm Sci; 2015 Aug; 76():138-48. PubMed ID: 25965961
[TBL] [Abstract][Full Text] [Related]
18. Structure-based design of novel dihydroisoquinoline BACE-1 inhibitors that do not engage the catalytic aspartates.
Bowers S; Xu YZ; Yuan S; Probst GD; Hom RK; Chan W; Konradi AW; Sham HL; Zhu YL; Beroza P; Pan H; Brecht E; Yao N; Lougheed J; Tam D; Ren Z; Ruslim L; Bova MP; Artis DR
Bioorg Med Chem Lett; 2013 Apr; 23(7):2181-6. PubMed ID: 23465612
[TBL] [Abstract][Full Text] [Related]
19. Aminoimidazoles as potent and selective human beta-secretase (BACE1) inhibitors.
Malamas MS; Erdei J; Gunawan I; Barnes K; Johnson M; Hui Y; Turner J; Hu Y; Wagner E; Fan K; Olland A; Bard J; Robichaud AJ
J Med Chem; 2009 Oct; 52(20):6314-23. PubMed ID: 19757823
[TBL] [Abstract][Full Text] [Related]
20. Novel approach of fragment-based lead discovery applied to renin inhibitors.
Tawada M; Suzuki S; Imaeda Y; Oki H; Snell G; Behnke CA; Kondo M; Tarui N; Tanaka T; Kuroita T; Tomimoto M
Bioorg Med Chem; 2016 Nov; 24(22):6066-6074. PubMed ID: 27720325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
